Royalty Pharma plc ( RPRX) - Key Metrics

RPRX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $1.51 $0.04 $1.54 $1.54
2026Q1 $1.46 $0.68 $1.76 $1.76
2025Q4 $1.44 $0.50 $1.92 $1.92
2025Q3 $1.41 $0.67 $1.63 $1.63
2025Q2 $1.37 $0.07 $0.86 $0.86

RPRX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 586.68% 350.44
2026Q1 35.42% 17.64
2025Q4 44.04% 15.09
2025Q3 33.07% 8.40
2025Q2 308.99% 95.72

RPRX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.75% 0.42%
2026Q1 3.67% 0.50%
2025Q4 4.96% 0.57%
2025Q3 4.61% 0.63%
2025Q2 2.39% 0.61%

RPRX

Price: $58.60

52 week price:
33.57
60.44

Dividend Yield: 1.60%

5-year range yield:
1.51%
3.00%

Forward Dividend Yield: 1.60%

Payout Ratio: 56.00%

Payout Ratio Range:
-18.46%
1963.27%

Dividend Per Share: 0.94 USD

Earnings Per Share: 1.90 USD

P/E Ratio: 30.51

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Ebitda: -16.0 million

Market Capitalization: 33.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 7

DGR3: 5.55%

Links: